Vivesto
VIVE | ST
Overview
Corporate Details
- ISIN(s):
- SE0000722365 (+4 more)
- LEI:
- 5493003TZPR4B7QO9L49
- Country:
- Sweden
- Address:
- Box 3061, 169 03 SOLNA
- Website:
- https://www.vivesto.com/en/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Vivesto AB is a specialty pharmaceutical company focused on thedevelopment of new therapeutic options for patients suffering from hard-to-treatcancers. It has an emerging pipeline of clinical-stage assets targeting late-stagecancers. Apealea® (paclitaxel micellar) is being made available to ovarian cancerpatients through a partnership with Elevar Therapeutics, Inc. Development programsinclude Cantrixil, in clinical development for late-stage ovarian cancer, and docetaxelmicellar, in development for advanced prostate cancer. Vivesto has proprietary drugdelivery technology designed to improve solubility, efficacy and safety.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-08 10:30 |
Regulatory News Service
Kommuniké från årsstämma i Vivesto AB
|
Swedish | 54.9 KB | |
| 2025-05-08 10:30 |
Regulatory News Service
Report from Annual General Meeting in Vivesto AB
|
English | 54.6 KB | |
| 2025-05-08 08:00 |
Quarterly Report
|
Swedish | 612.7 KB | |
| 2025-03-18 07:15 |
Inside Information Statement
Vivesto licenses Apealea to China’s Zhida Pharmaceutical
|
English | 64.5 KB | |
| 2025-03-18 07:15 |
Inside Information Statement
Vivesto utlicensierar Apealea till kinesiska Zhida Pharmaceutical
|
Swedish | 64.9 KB | |
| 2025-02-20 08:00 |
Earnings Release
|
Swedish | 935.6 KB | |
| 2024-11-21 08:00 |
Quarterly Report
|
Swedish | 3.4 MB | |
| 2024-11-07 10:54 |
Regulatory News Service
Vivesto signs Apealea option agreement with Zhida Pharmaceutical
|
English | 63.9 KB | |
| 2024-11-07 10:54 |
Regulatory News Service
Vivesto ingår optionsavtal för Apealea med Zhida Pharmaceutical
|
Swedish | 64.3 KB | |
| 2024-08-22 08:00 |
Earnings Release
|
Swedish | 917.1 KB | |
| 2024-05-23 10:48 |
Declaration of Voting Results & Voting Rights Announcements
Report from Annual General Meeting in Vivesto AB
|
English | 55.7 KB | |
| 2024-05-23 10:48 |
Declaration of Voting Results & Voting Rights Announcements
Kommuniké från årsstämma i Vivesto AB
|
Swedish | 55.7 KB | |
| 2024-05-23 08:00 |
Quarterly Report
|
Swedish | 900.5 KB | |
| 2024-04-23 08:05 |
Annual Report
|
Swedish | 13.4 MB | |
| 2024-04-23 08:00 |
General Meeting Notice
Kallelse till årsstämma i Vivesto AB
|
Swedish | 90.6 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2021-08-19 | Anders Härfstrand | Other | Buy | 20,000 | 53,132.58 SEK |
| 2021-07-16 | Peter Zonabend | Other | Buy | 100,000 | 302,623.60 SEK |
| 2021-07-14 | Fredrik Järrsten | Other | Buy | 20,000 | 58,200.00 SEK |
| 2021-07-13 | Francois-Regis Martelet | Other | Buy | 41,000 | 121,370.00 SEK |
| 2021-07-08 | Birgit Agneta Stattin Norinder | Other | Buy | 35,000 | 104,480.00 SEK |
| 2021-07-06 | Anders Härfstrand | Other | Buy | 100,000 | 285,653.00 SEK |
| 2020-10-13 | Francois-Regis Martelet | Other | Buy | 20,000 | 85,000.00 SEK |
| 2020-10-12 | Anders Härfstrand | Other | Buy | 30,000 | 130,800.00 SEK |
| 2020-06-18 | Sven Rohmann | Other | Sell | 100,000 | 620,638.00 SEK |
| 2020-06-18 | Sven Rohmann | Other | Sell | 78,370 | 504,702.80 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
AstraZeneca PLC | United Kingdom | AZN | |
|
Basilea Pharmaceutica AG | Switzerland | BSLN | |
|
Bayer AG | Germany | BAY | |
|
Biogened Spolka Akcyjna | Poland | BGD | |
|
Biotika A.S. | Slovakia | BSL | |
|
Bio Vitos Pharma AB | Sweden | BIOVIT | |
|
BOIRON | France | BOI | |
|
Bonyf N.V. | Belgium | MLBON | |
|
Bosnalijek d.d. Sarajevo | Bosnia and Herzegovina | BSNL | |
|
Calliditas Therapeutics | Sweden | CALTX |